Background and Purpose-Prompt recognition of stroke symptoms is critical to timely treatment and women have increased delay to treatment. Women may be more likely to present with atypical symptoms, but this hypothesis has not been extensively evaluated. Methods-We examined gender differences in the prevalence of presenting and prodromal stroke symptoms among 1107 consecutive patients hospitalized with neurologist-confirmed acute ischemic stroke. Patient demographics, clinical variables, and stroke symptoms were abstracted from medical records by trained abstractors using standardized forms.Estimates were age-standardized to the age distribution of men and women combined. Presenting symptoms occurred within 24 hours of incident stroke admission; prodromal symptoms occurred Ն24 hours of admission. Results-Women were significantly older (PϽ0.001), more likely to have cardioembolic stroke (PϽ0.01), and less likely to receive aspirin (Pϭ0.014) or statins (PϽ0.001). Thirty-five percent of the sample (nϭ389) reported prodromal symptoms. Women were more likely to have Ն1 somatic prodromal and presenting symptoms (Pϭ0.03; Pϭ0.008), but did not differ from men on specific somatic symptoms. Women did not differ from men in classic presenting stroke symptoms (Pϭ0.89). Conclusion-Women did not differ significantly in the prevalence of traditional stroke symptoms but were more likely to have somatic presenting and prodromal symptoms. We found no differences in specific prodromal symptoms, making it difficult to craft a public health message about gender differences in early warning signs of stroke. These results suggest that the focus of stroke prevention education for women should continue to emphasize traditional stroke risk factors.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.